Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Matsui

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 8, 2017
Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virusYusuke Sato, Hideki Matsui, Naoki Yamamoto, et al.
Neuroscience Research|March 3, 2005
Regulation of synaptic vesicle recycling by calcineurin in different vesicle poolsSusumu Kumashiro, Yun-Fei Lu, Kazuhito Tomizawa, et al.
Biomaterials|February 13, 2010
Development of a bifunctional immunoliposome system for combined drug delivery and imaging in vivoBin Feng, Kazuhito Tomizawa, Hiroyuki Michiue, et al.
Biomaterials|March 8, 2014
The transdermal inhibition of melanogenesis by a cell-membrane-permeable peptide delivery system based on poly-arginineNanako Ookubo, Hiroyuki Michiue, Mizuki Kitamatsu, et al.
Neuroscience Research|August 28, 2003
Poly-arginine-fused calpastatin peptide, a living cell membrane-permeable and specific inhibitor for calpainHai-Yan Wu, Kazuhito Tomizawa, Masayuki Matsushita, et al.
Neuro-Oncology|March 18, 2009
Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomasShin-Ichi Miyatake, Shinji Kawabata, Naosuke Nonoguchi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 30, 2002
Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activityKazuhito Tomizawa, Jun Ohta, Masayuki Matsushita, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 22, 2002
Calcineurin plays different roles in group II metabotropic glutamate receptor- and NMDA receptor-dependent long-term depressionSheng-Tian Li, Kunio Kato, Kazuhito Tomizawa, et al.
Biomaterials|May 3, 2015
Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor modelYoshiya Iguchi, Hiroyuki Michiue, Mizuki Kitamatsu, et al.
Molecular Cancer Therapeutics|December 17, 2002
Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cellsToshihiko Takenobu, Kazuhito Tomizawa, Masayuki Matsushita, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 8, 2017
Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virusYusuke Sato, Hideki Matsui, Naoki Yamamoto, et al.
Neuroscience Research|March 3, 2005
Regulation of synaptic vesicle recycling by calcineurin in different vesicle poolsSusumu Kumashiro, Yun-Fei Lu, Kazuhito Tomizawa, et al.
Biomaterials|February 13, 2010
Development of a bifunctional immunoliposome system for combined drug delivery and imaging in vivoBin Feng, Kazuhito Tomizawa, Hiroyuki Michiue, et al.
Biomaterials|March 8, 2014
The transdermal inhibition of melanogenesis by a cell-membrane-permeable peptide delivery system based on poly-arginineNanako Ookubo, Hiroyuki Michiue, Mizuki Kitamatsu, et al.
Neuroscience Research|August 28, 2003
Poly-arginine-fused calpastatin peptide, a living cell membrane-permeable and specific inhibitor for calpainHai-Yan Wu, Kazuhito Tomizawa, Masayuki Matsushita, et al.
Neuro-Oncology|March 18, 2009
Pseudoprogression in boron neutron capture therapy for malignant gliomas and meningiomasShin-Ichi Miyatake, Shinji Kawabata, Naosuke Nonoguchi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 30, 2002
Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activityKazuhito Tomizawa, Jun Ohta, Masayuki Matsushita, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 22, 2002
Calcineurin plays different roles in group II metabotropic glutamate receptor- and NMDA receptor-dependent long-term depressionSheng-Tian Li, Kunio Kato, Kazuhito Tomizawa, et al.
Biomaterials|May 3, 2015
Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor modelYoshiya Iguchi, Hiroyuki Michiue, Mizuki Kitamatsu, et al.
Molecular Cancer Therapeutics|December 17, 2002
Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cellsToshihiko Takenobu, Kazuhito Tomizawa, Masayuki Matsushita, et al.
Pageof 11